BioVie (BIVI)
US Market

BioVie (BIVI) Financial Statements


BioVie Financial Overview

BioVie's market cap is currently ―. The company's EPS TTM is $-0.961; its P/E ratio is -0.50; BioVie is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.58M$ -9.71M-$ 14.16M-
EBITDA$ -7.49M$ -9.61M-$ 14.10M-
Net Income Common Stockholders$ -8.40M$ -10.71M-$ 15.06M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 20.23M$ 21.21M$ 19.46M$ 31.28M$ 0.00
Total Assets$ 21.49M$ 23.76M$ 35.10M$ 45.18M-
Total Debt$ 10.26M$ 12.39M$ 14.42M$ 13.89M$ 0.00
Net Debt$ -9.97M$ -8.83M$ -5.04M$ -17.38M$ 0.00
Total Liabilities$ 14.00M$ 16.21M$ 19.76M$ 23.46M-
Stockholders Equity$ 7.49M$ 7.55M$ 15.34M$ 21.72M$ 0.00
Cash Flow-
Free Cash Flow$ -5.91M$ -12.18M$ -11.32M-$ -8.00M
Operating Cash Flow$ -5.91M$ -12.18M$ -11.32M--
Investing Cash Flow-$ 14.53M$ -1.80M--
Financing Cash Flow$ 4.92M$ -594.16K$ 1.27M--
Currency in USD

BioVie Earnings and Revenue History

BioVie Debt to Assets

BioVie Cash Flow

BioVie Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis